logo
episode-header-image
Apr 2022
7m 29s

Tasty Morsels of Critical Care 060 | The...

Andy Neill
About this episode

Welcome back to the tasty morsels of critical care podcast.

Oh chapter 26 devotes a whole chapter to this and for those of us in cardiac units the arrival of several post cardiac surgery patients a day in your unit is a routine part of the day. At least it was pre-pandemic anyhow. As such it presents a fairly predictable work load and patient cohort for your ICU. Given the bewildering number of conditions that can present to a mixed ICU on a given day, knowing that you have a couple of hearts moving along the production line provides a degree of predictability to the workflow.

The scheduled, usually elective nature of cardiac surgery lends itself to large scale outcome prediction and indeed, cardiac surgery has found its outcomes examined very closely over the past few decades. Outcomes are often examined in great detail and are more likely than most patient cohorts to be reflected onto the hospital and even individual surgeons.

Today we’ll focus mainly on the routine cardiac surgery patient and some of the common significant issues you’ll see.

Before we look at any specific cardiac surgeries, it is worth addressing the hand over. There is frankly a lot of information to assimilate and sift through. You will often be receiving handover from the anaesthesia team but also trying to tease out information from the surgeons almost simultaneously. Key points of information to glean are:

  • pre surgical state, including what the heart looked like on TOE pre bypass – eg. is the ventricle good or bad at baseline
  • what was done and how the plumbing stands as of now
  • bypass time, cross clamp time
  • how did separation from bypass go – are they on 2 pressors and 2 inotropes and some nitric? or have they arrived on some propofol and a tincture of noradrenaline and a big sticky label saying “extubate me”
  • heart rhythm and presence and need for pacing (indeed if not being used is it at least on backup?)
  • what did the heart look like on TOE following the surgery – is the valvular lesion fixed? are they, dare i use the terrible phrase, “underfilled”
  • products given and current state of reversal and need for protamine
  • where the drains are and what they’re doing (are they just mediastinal or are they pleural too? Was that 400mls of red stuff there when you left theatre or has it just appeared)

Contra to most ICU patients, cardiac surgery patients often benefit from a bit of the salty water stuff. Likely driven by rewarming induced vasodilation and hypothermia induced diuresis they can be hypovolaemic. It doesn’t take them long to transition to the more conventional ICU patient where fluid does nothing but increase the oedema but in the first 6-12 hours fluid resuscitation often has a role.

Episodes of hypotension are common and the major concerning causes are going to be surgical bleeding or tamponade. The drains that you checked at handover are both diagnostic and therapeutic. A big gush of blood from the drain and hypotension usually points to the problem while at the same time relieving any potential tamponade. Significant bleeding might be >200ml/hr in the first hour or two and >100ml/hr after that.

Unfortunately blood can clot focally around the heart causing a focal tamponade. This can be a bit trickier to diagnose as one might imagine, and indeed some form of imaging is often needed to make the diagnosis. Oh is very down on the utility of TTE in cardiac surgery patients and while of course you aren’t going to get all the windows, a good sonographer can usually answer many of the key questions. That being said if the patient is crashing you often need a TOE to look at the tricky spots like behind the LA where clots have tendency to form obstructing LA inflow. Both surgical bleeding and tamponade are surgical issues that once diagnosed should prompt a return to theatre. Any major issues with shock in the first 12-24 hrs should always have “return to theatre” somewhere on the list of possibilities. Finally for tamponade don’t forget the CVP. While much maligned in general critical care, when it comes to cardiac surgical patients the CVP provides some nice screening information for issues like tamponade and RV function

Atrial fibrillation is common everywhere in the ICU and it is unsurprisingly common in the cardiac surgery population. Its incidence comes in somewhere around 20%. Much of it occurs beyond the first 24 hrs, often when they have left my particular unit. Causes are numerous and much of the basics will happen automatically with correction of potassium and magnesium. It remains unclear what the best way is to manage cardiac surgery related a fib, but the usual suspects of beta blockers and amiodarone are the commonest interventions with vitamin A leading the way, particularly when they’re still a bit sick and shocked and ventilated, and beta blockers playing more of a role once the tube is out and the pressors are gone. Cardioversion is probably not the way to go for these patients.

Interestingly I just read an RCT that suggesting leaving the pericardium open a small bit at the end of surgery reduced the rates of post op a fib from 30% to 17% with no significant consequences. It was single centre and may well disappear into the midst of unreproducible research but would be a nice move if it turns out.

Reading:

Oh Chapter 26

 

Up next
Nov 24
Tasty Morsels of Critical Care 091 | Pulmonary Embolism Management
<p>Welcome back to the <a href="https://emergencymedicineireland.com/the-tasty-morsels">tasty morsels of critical care podcast</a>.</p> <p>This is the second of 2 parts on PE in critical care. The first focused on risk stratification and this one will focus on management. There i ... Show More
10m 59s
Nov 10
Tasty Morsels of Critical Care 090 | Pulmonary Embolism Risk Stratification
<p>Welcome back to the <a href="https://emergencymedicineireland.com/the-tasty-morsels">tasty morsels of critical care podcast</a>.</p> <p>I haven&#8217;t managed to cover PE on the podcast yet. I have been involved in lots of small PE projects over the years and have developed s ... Show More
8m 3s
Sep 29
Tasty Morsels of Critical Care 089 | Hypertriglyceridemia-induced acute pancreatitis
<p>Welcome back to the <a href="https://emergencymedicineireland.com/the-tasty-morsels">tasty morsels of critical care podcast</a>.</p> <p>Hypertriglyceridaemua induced pancreatitis came up at a recent trainee presentation and I thought despite it being pretty niche and rare, it& ... Show More
4m 32s
Recommended Episodes
Mar 2022
Episode 009: Cytopenias Series Pt. 1 - Thrombocytopenia
<p class="" style="white-space:pre-wrap;">One of our most common consults in hematology is teams seeking guidance for workup and management of thrombocytopenia. In this episode, we cover our approach to this hematologic conundrum. </p><p class="" style="white-space:pre-wrap;">Ma ... Show More
27m 24s
Mar 2025
414. Case Report: Got Milky Blood? Hypertriglyceridemia Unveiled in a Case of Abdominal Pain – National Lipid Association
CardioNerds co-founders Dr. Daniel Ambinder and Dr. Amit Goyal are joined by Dr. Spencer Weintraub, Chief Resident of Internal Medicine at Northwell Health, Dr. Michael Albosta, third-year Internal Medicine resident at the University of Miami, and Anna Biggins, Registered Dietiti ... Show More
1h 17m
Jan 2025
Review of the Primary Angioplasty in Myocardial Infarction Study Group trial
N Engl J Med 1993;328:673-679Background: Previous trials established that thrombolysis improves mortality in patients with acute myocardial infarction, as seen in the GISSI-1 and ISIS-2 trials. However, thrombolysis has limitations, including an increased risk of bleeding and the ... Show More
12m 26s
Feb 2025
410. Case Report: A Curious Case of Refractory Ventricular Tachycardia – Rutgers-Robert Wood Johnson
CardioNerds (Dr. Colin Blumenthal and Dr. Saahil Jumkhawala) join Dr. Rohan Ganti, Dr. Nikita Mishra, and Dr. Jorge Naranjo from the Rutgers – Robert Wood Johnson program for a college basketball game, as the buzz around campus is high. They discuss the following case involving a ... Show More
40m 13s
Apr 2024
Episode 899: Thrombolytic Contraindications
<p dir="ltr"><strong>Contributor: Travis Barlock MD</strong></p> <p dir="ltr"><strong>Educational Pearls:</strong></p> <ul> <li dir="ltr" aria-level="1"> <p dir="ltr" role="presentation">Thrombolytic therapy (tPA or TNK) is often used in the ED for strokes</p> </li> <li dir="ltr" ... Show More
3m 51s
May 2025
Episode 209: Blast Crisis
<div class="row"> <div class="col-sm-4"> <a href="https://coreem.net/podcast/episode-209-blast-crisis/" title="Episode 209: Blast Crisis" rel="bookmark"> <img width="576" height="576" src="https://coreem.net/content/uploads/2025/04/Blast-Crisis.001.j ... Show More
10m 15s
Dec 2024
Episode 936: Etomidate vs. Ketamine for Rapid Sequence Intubation
<p dir="ltr"><strong>Contributor: Ricky Dhaliwal MD</strong></p> <p dir="ltr"><strong>Educational Pearls: </strong></p> <ul> <li dir="ltr" aria-level="1"> <p dir="ltr" role="presentation">Etomidate was previously the drug of choice for rapid sequence intubation (RSI)</p> </li> <u ... Show More
4m 58s
Feb 2024
Myocarditis
<p>Myocarditis is the inflammation of the heart muscle. This muscle is the middle layer of the heart, formally called the myocardium, hence the name myocarditis (the -itis suffix indicates inflammation). Inflammation of the myocardium can be caused by a variety of etiologies, fro ... Show More
21m 42s
Jan 2025
Episode 204: Necrotizing Fasciitis
<div class="row"> <div class="col-sm-4"> <a href="https://coreem.net/podcast/episode-204-necrotizing-fasciitis/" title="Episode 204: Necrotizing Fasciitis" rel="bookmark"> <img width="576" height="576" src="https://coreem.net/content/uploads/2025/01/ ... Show More
9m 12s
Jun 2025
Clopidogrel Versus Aspirin For Long-term Maintenance Monotherapy In Patients With High Ischemic Risk After PCI
The SMART-CHOICE 3 trial demonstrated that clopidogrel monotherapy is more effective than aspirin monotherapy in reducing the risk of major adverse cardiac and cerebrovascular events in high-risk patients who completed standard dual antiplatelet therapy (DAPT) following percutane ... Show More
9m 15s